Results 181 to 190 of about 72,294 (253)

Chemical Diversity and Biological Significance of Sesquiterpene Lactones: From Biosynthesis to Anticancer Mechanisms

open access: yesChemistry &Biodiversity, Volume 23, Issue 10, October 2026.
Sesquiterpene lactones emerge as structurally diverse anticancer scaffolds with multifaceted mechanisms of action. Their biosynthesis, chemical diversity, structure–activity relationships, semisynthetic diversification, and molecular targets are integrated to highlight therapeutic opportunities and challenges.
Kedar Nimba Chaudhari   +3 more
wiley   +1 more source

Phytochemistry, Pharmacological Potential, and Future Prospects of Abietane‐Type Diterpenoids From Salvia rosmarinus

open access: yesChemistry &Biodiversity, Volume 23, Issue 10, October 2026.
The review delves into the findings on abietane diterpenes from Salvia rosmarinus. It comprises the phytochemistry, biological activities, biosynthesis, degradation studies, semisynthesis, and pharmacokinetic studies of these compounds. The potential of these compounds for future development has also been highlighted.
Rida Siddiqui, Vipin Singh, Kapil Dev
wiley   +1 more source

Imine Reductase‐Mediated Regio‐ and Stereoselective Reductive Amination of Diamines

open access: yesChemCatChem, Volume 18, Issue 19, 14 October 2026.
Imine reductases (IREDs) have been employed as biocatalysts for the regioselective modification of diamines via reductive amination. The use of racemic diamines resulted in both regio‐ and enantio‐selective reductive amination via kinetic resolution. The application of this methodology has been demonstrated on a preparative scale by the synthesis of a ...
Arnau Rué Casamajo   +7 more
wiley   +1 more source

Targeting Menin in T-lineage Acute Lymphoblastic Leukemia. [PDF]

open access: yesMol Cancer Ther
Shimamoto K   +16 more
europepmc   +1 more source

Race and Socioeconomic Status are Predictors of Survival in Patients With Metastatic Bone Disease Secondary to Breast Cancer

open access: yesCancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background With implementation of early detection screening methods and advances in medical treatment, there have been improvement in outcomes for patients with breast cancer. Despite this, studies have suggested potential differences in outcomes amongst various racial and ethnic groups.
Ashley Castan   +8 more
wiley   +1 more source

Advancing Blue‐Light Photoactivatable TAM Kinase Inhibitors for Cancer Treatment: Challenges in Using π‐Extended Coumarins as Photocleavable Protecting Groups

open access: yesChemPhotoChem, Volume 10, Issue 10, October 2026.
Promise and obstacles of π‐extended coumarin as photolabile protecting groups for blue‐light photoactivatable TAM kinase inhibitors. We developed a series of photocleavable TAM kinase inhibitors that incorporate various π‐extended coumarins as photoremovable groups, enabling blue‐light activation.
Sébastien Billotte   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy